http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-029989-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e900a29b2bb365a93fa933eecffb915
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-001
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
filingDate 2001-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1a94f746dc8dc78f1e766d593dbb8bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1957774a4500cb17670281f13e176a09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1967f181b6bb89cf758bd7f089342397
publicationDate 2003-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-029989-A1
titleOfInvention STEROID COMPOUNDS 16 ALFA-SUBSTITUTES FOR USE IN TREATMENTS RELATED TO STROGEN RECEIVERS
abstract 16alpha-substituted steroid compound having formula (1), where the dotted line ring is a fully saturated ring, a fully aromatic ring or a saturated ring with a double delta5-10 bond; R1 is C1-3 alkyl or C2-3 alkenyl, and each of these groups may be substituted with one or more halogens; R2 is C1-4 alkyl, C2-4 alkenyl, or methylene, and each of these groups may be substituted with one or more halogens; R3 is methyl or ethyl; or a prodrug thereof, whose compound can be used for a selective treatment for alpha estrogen receptors.
priorityDate 2000-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705

Total number of triples: 33.